The benzodiazepine-dependent patient - Perioperative considerations;Der benzodiazepinabhangige patient - Perioperative uberlegungen

Anasthesiologie und Intensivmedizin

Volumn 39, Issue 1, 1998, Pages 30-41

  Freye, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bezodiazepam; Substance abuses; Substance dependent; Substanceece Susbtance wihhdrawal syndrpme

Indexed keywords

ALPRAZOLAM; ANESTHETIC AGENT; BROMAZEPAM; BROTIZOLAM; CAMAZEPAM; CHLORDIAZEPOXIDE; CLOBAZAM; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; CLOTIAZEPAM; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; KETAZOLAM; LORAZEPAM; LORMETAZEPAM; MEDAZEPAM; MIDAZOLAM; MIDAZOLAM MALEATE; NITRAZEPAM; OXAZEPAM; OXAZOLAM; PRAZEPAM; TEMAZEPAM; TETRAZEPAM; TRIAZOLAM;

ARTICLE; DRUG DEPENDENCE; DRUG POTENTIATION; DRUG SAFETY; EPILEPSY; HUMAN; PREMEDICATION; PREOPERATIVE EVALUATION; RESPIRATION DEPRESSION; TRANQUILIZING ACTIVITY; TREATMENT PLANNING; WITHDRAWAL SYNDROME;

EID: 0031916037     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chan AWK. (1984) Effects of combined alcohol and benzodiazepine: a review. Drug Alcohol Depend 13: 315-329.
2. Clarke CH, Nicholson AN (1978) Immediate and residual effects in man of the metabolites of diazepam. Brit J clin Pharmacol 6: 325-.
3. Costa E, Guidotti A (1979) Molecular mechanisms in the receptor action of benzodiazepines.Ann Rev Pharmacol Toxicol 19: 531-545.
4. Fleischhacker WW (1988) Dependence potentials of benzodiazepines. Lancet II: 504-510.
5. Freye E. (1994) Opioide in der Medizin. Berlin, Heidelberg, New York, Springer.
6. Freye E, Neruda B et al. (1989) Flumazenil (Anexate®) for the reversal of residual benzodiazepine activity. Drugs Today 25: 119-124.
7. Geller E, Crome P et al. (1991) Risk and benefits of therapy with flumazenil (Anexate®) in mixed drug intoxications. Eur Neurol 31: 241-250.
8. Haefely WE, Möhler H (1980). Der Wirkungsmechanismus der Benzodiazepine. Basel, Hoffmann-La Roche.
9. Jones DM et al (1978) The effects of low doses of diazepam on human performance in group administered task. Brit J Clin Pharmacol 6: 333-.
10. Keup W (1993) Mißbrauchmuster bei Abhängigkeit von Alkohol, Medikamenten und Drogen. Frühwarnsystem-Daten für die Bundesrepublik Deutschland 1976-1990. Freiburg, Lambertus.
11. Koehler K, Saß H (1984) Diagnostisches und statistisches Manual psychischer Störungen. DSM III. Weinheim, Basel, Beiz.
12. Lader MH, Morton S (1991). Benzodiazepine problems. Brit J Addict 86: 823-827.
13. Laux G, König W (1985) Benzodiazepine: Langzeiteinnahme oder Abusus. Dt Med Wochensch 110: 1285-1290.
14. Leuner V (1991) Schlaf, Schlafstörungen, Schlafmittel. Basel, Editiones Roche.
15. Long RE, Penna RF (1968) Drugs of abuse. J Amer Pharmaceutic Ass 58: 12.
16. Luderer HJ (1986) Suchtgefahren im Alter. Nervenheilkunde 5: 195-198.
17. Moehler H, Okada T (1977) Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849-851.
18. Poser W, Poser S et al (1985) Pharmakologische und klinische Daten zum Problem der Benzodiazepin-Abhängigkeit. In: Hippius H (Hrsg) Buspiron-Workshop. Neue Entwicklungen der Pharmakotherapie der Angst. München, Edition Materia Medica, Socio-Medico.
19. Poser W, Poser S. (1996). Medikamente- Mißbrauch und Abhängigkeit. Stuttgart, New York, Thieme.
20. Priebe S (1988) Resumption of benzodiazepine use after withdrawal in hospital- a follow up study. Pharmacopsychiatry 21: 353-361.
21. Rickels SC et al (1990). Long-term treatment of anxiety and risk of withdrawal. Arch gen Psychiat 45: 444-454.
22. Schmidt LG, Grohmann R et al. (1990) Mißbrauch von Antidepressiva bei Suchtkrankheiten. Dt Ärztebl 87: C-84 - C-86.
23. Squires RF, Baestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266: 732-734.
24. Stone BM. (1979) Diazepam and its hydroxylated metabolites: studies on sleep in healthy man. Brit J Clin Pharmacol 8: 57S.
25. Wolter-Hensler D, Gadatsch MA et al. (1994) Depression und Benzodiazepinabhängigkeit im Alter. Psychiat Prax 21: 157-159.